業績
Selected publications
1. Li, Y*., Hirayasu, K*. (*co-first authors) et al. Front. Immunol. in press
2. Hirayasu, K., Khor, S.-S., Kawai, Y., Shimada, M., Omae, Y., Hasegawa, G., Hashikawa,
Y., Tanimoto, H., Ohashi, J., Hosomichi, K., Tajima, A., Nakamura, H.,
Nakamura, M., Tokunaga, K., Hanayama, R. & Nagasaki, M. Identification
of the hybrid gene LILRB5-3 by long-read sequencing and implication of
its novel signaling function. Front. Immunol. 15, 1398935 (2024).
3. Hirayasu, K., Sun, J., Hasegawa, G., Hashikawa, Y., Hosomichi, K., Tajima, A., Tokunaga,
K., Ohashi, J. & Hanayama, R. Characterization of LILRB3 and LILRA6
allelic variants in the Japanese population. J Hum Genet 66, 739–748 (2021).
4. Hirayasu, K. & Arase, H. Leukocyte Immunoglobulin-Like Receptor (LILR). Encyclopedia of Signaling Molecules 2nd Edition, (2018).
5. Deng, M., Gui, X., Kim, J., Xie, L., Chen, W., Li, Z., He, L., Chen,
Y., Chen, H., Luo, W., Lu, Z., Xie, J., Churchill, H., Xu, Y., Zhou, Z.,
Wu, G., Yu, C., John, S., Hirayasu, K., Nguyen, N., Liu, X., Huang, F., Li, L., Deng, H., Tang, H., Sadek, A.
H., Zhang, L., Huang, T., Zou, Y., Chen, B., Zhu, H., Arase, H., Xia, N.,
Jiang, Y., Collins, R., You, M. J., Homsi, J., Unni, N., Lewis, C., Chen,
G.-Q., Fu, Y.-X., Liao, X. C., An, Z., Zheng, J., Zhang, N. & Zhang,
C. C. LILRB4 signalling in leukaemia cells mediates T cell suppression
and tumour infiltration. Nature 562, 605–609 (2018).
6. Saito, F*., Hirayasu, K*. (*co-first authors), Satoh, T., Wang, C. W., Lusingu, J., Arimori, T.,
Shida, K., Palacpac, N. M. Q., Itagaki, S., Iwanaga, S., Takashima, E.,
Tsuboi, T., Kohyama, M., Suenaga, T., Colonna, M., Takagi, J., Lavstsen,
T., Horii, T. & Arase, H. Immune evasion of Plasmodium falciparum by
RIFIN via inhibitory receptors. Nature 552, 101–105 (2017).
7. Hirayasu, K., Saito, F., Suenaga, T., Shida, K., Arase, N., Oikawa, K., Yamaoka, T.,
Murota, H., Chibana, H., Nakagawa, I., Kubori, T., Nagai, H., Nakamaru,
Y., Katayama, I., Colonna, M. & Arase, H. Microbially cleaved immunoglobulins
are sensed by the innate immune receptor LILRA2. Nat Microbiol 1, 16054 (2016).
8. Hirayasu, K. & Arase, H. Functional and genetic diversity of leukocyte immunoglobulin-like
receptor and implication for disease associations. J Hum Genet 60, 703–8 (2015).
9. Hirayasu, K., Ohashi, J., Kashiwase, K., Hananantachai, H., Naka, I., Ogawa, A., Takanashi,
M., Satake, M., Nakajima, K., Parham, P., Arase, H., Tokunaga, K., Patarapotikul,
J. & Yabe, T. Significant association of KIR2DL3-HLA-C1 combination
with cerebral malaria and implications for co-evolution of KIR and HLA.
PLoS Pathog 8, e1002565 (2012).
10. Yabe, T., Matsuo, K., Hirayasu, K., Kasbiwase, K., Kawamura-Ishii, S., Tanaka, H., Ogawa, A., Takanshi,
M., Satake, M., Nakajima, K., Tokunaga, K., Inoko, H., Saji, H., Ogawa,
S., Juji, T., Sasazuki, T., Kodera, Y. & Morishima, Y. Donor killer
immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand
combination and antithymocyte globulin preadministration are critical factors
in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone
marrow transplantation. Biol Blood Marrow Transplant 14, 75–87 (2008).
11. Hirayasu, K., Ohashi, J., Tanaka, H., Kashiwase, K., Ogawa, A., Takanashi, M., Satake,
M., Jia, G. J., Chimge, N. O., Sideltseva, E. W., Tokunaga, K. & Yabe,
T. Evidence for natural selection on leukocyte immunoglobulin-like receptors
for HLA class I in Northeast Asians. Am J Hum Genet 82, 1075–83 (2008).
12. Hirayasu, K., Ohashi, J., Kashiwase, K., Takanashi, M., Satake, M., Tokunaga, K. &
Yabe, T. Long-term persistence of both functional and non-functional alleles
at the leukocyte immunoglobulin-like receptor A3 (LILRA3) locus suggests
balancing selection. Hum Genet 119, 436–43 (2006).